protein
produc
bodi
control
mediat
metabol
process
help
routin
function
kind
impair
protein
product
product
mutat
protein
misfold
protein
lead
disrupt
pathway
control
protein
may
manifest
form
diseas
howev
diseas
treat
suppli
protein
outsid
exogen
suppli
activ
exogen
protein
requir
product
larg
scale
fulfil
grow
demand
process
complex
requir
higher
protein
express
purif
process
product
need
uniqu
set
standard
largescal
product
purif
largescal
product
fulfil
grow
demand
thu
need
costeffect
tool
genet
engin
util
produc
protein
human
origin
bacteria
fungi
insect
mammalian
host
fig
usag
recombin
dna
technolog
largescal
product
protein
requir
ampl
amount
time
labor
resourc
also
offer
mani
opportun
econom
growth
read
chapter
reader
would
abl
understand
basic
product
recombin
protein
variou
host
along
advantag
limit
host
system
properti
product
import
pharmaceut
compound
growth
factor
promot
rnapol
ii
allow
differenti
express
gene
determin
rate
gene
transcrib
promot
caus
insert
gene
express
time
part
system
known
constitut
promot
other
allow
express
certain
stagescertain
tissueorgan
individu
certain
time
point
gene
express
tempor
spatial
regul
prokaryot
posit
start
site
interact
subunit
holoenzym
rna
polymeras
eukaryot
sequenc
analog
sequenc
prokaryot
tataaaa
present
posit
promot
region
eukaryot
promot
shown
fig
tata
box
form
core
promot
posit
upstream
transcript
start
site
caat
box
gc
box
approxim
respect
locat
promot
alway
dna
molecul
regul
refer
cisact
element
space
variou
element
import
much
depend
locusspecif
activ
either
core
promot
distant
site
variou
signal
enhanc
also
involv
far
apart
target
gene
exert
stimulatori
effect
promot
activ
upstream
downstream
middl
gene
promot
housekeep
gene
gene
complex
pattern
express
cpg
island
rather
tata
box
gene
transcrib
region
utr
exon
code
region
separ
intron
noncod
region
end
region
utr
clone
gene
express
usual
intronless
version
gene
use
eukaryot
transcript
enhanc
enhanc
may
base
away
promot
region
abl
affect
rate
transcript
simplest
host
work
recombin
dna
technolog
prokaryot
bacteri
system
earli
first
recombin
fdaapprov
pharmaceut
human
insulin
humulinushumulineeu
obtain
genet
engin
escherichia
coli
e
coli
treatment
diabet
due
increas
demand
mani
strain
microbi
speci
design
increas
throughput
better
recoveri
therapeut
protein
largescal
cultur
recombin
protein
approv
fda
obtain
either
escherichia
coli
prokaryot
saccharomyc
cerevisia
fungal
speci
insect
cell
mammalian
cell
human
cell
transgen
plant
anim
clone
product
protein
particular
host
system
depend
upon
properti
host
clone
express
desir
size
proteinencod
gene
product
correctli
modifi
fold
function
protein
high
yield
protein
lowcost
requir
choic
host
system
requir
best
system
fulfil
requir
advantag
produc
protein
use
recombin
dna
technolog
human
gene
may
clone
express
minim
risk
immun
reaction
specif
activ
protein
highth
therapeut
protein
produc
effici
maintain
costeffectivenessit
minim
risk
transmiss
unknown
pathogen
present
anim
human
sourcesappropri
modif
higher
specif
increas
halflif
improv
functionalityallow
creat
critic
chang
better
specif
activ
express
product
eukaryot
protein
requir
clone
cdna
express
vector
subsequ
transfer
vector
suitabl
host
dna
modifi
clone
express
host
product
protein
thu
optimum
product
condit
requir
host
howev
yield
variat
differ
express
system
highlevel
express
protein
may
achiev
consid
follow
point
recombin
gene
necessari
element
effect
transcript
initiationus
made
strong
viral
cellular
promoterenhanc
effici
drive
transcript
usag
viral
promot
bacteria
result
higher
yield
recombin
protein
transgen
may
express
control
either
polyhedrin
promot
baculoviru
promoterof
adenoviru
promoterof
vaccinia
viru
suitabl
wide
rang
cell
type
mammalian
cell
may
use
promot
enhanc
longterminalrepeat
promot
enhanc
rou
sarcoma
viru
earli
promot
human
cytomegaloviru
refer
chap
promot
express
vector
polyadenyl
signal
help
eukaryot
gene
termin
requir
defin
end
mrna
extend
addit
poli
tail
ultim
increas
stabil
rna
facilit
export
cytoplasmremov
utr
untransl
repeat
may
influenc
gene
express
may
interfer
initi
translat
secondari
structur
prevent
effici
translationkozak
consensu
purin
posit
guanin
posit
affect
transgen
expressioninclus
one
intron
sequenc
locat
promot
cdna
code
sequenc
give
better
yield
thu
express
vector
includ
least
one
intron
sequenc
intron
presenc
import
transgen
need
express
mammalian
cellsfor
elimin
slow
rate
translat
due
codon
bias
gene
may
convert
highexpress
gene
chang
trna
codon
abund
onesth
integr
site
major
effect
rate
transcript
recombin
gene
posit
effect
select
gene
like
dihydrofol
reductas
dhfr
glutamin
synthetas
gs
gene
incorpor
gene
involv
nucleotid
biosynthesi
glutamin
synthetas
respect
select
occur
appropri
metabolit
miss
prevent
growth
nontransform
cellsfor
increas
yield
recombin
protein
protein
often
fuse
endogen
protein
sequenc
see
chap
select
marker
report
aid
purif
proteinencod
dna
contain
code
dna
specif
protein
peptid
target
affin
chromatographyfor
affin
purif
two
system
readili
employ
glutathion
stransferas
gst
affin
ion
affin
gst
high
affin
glutathion
protein
side
chain
histidin
high
affin
nickel
ionsstabl
transfect
give
high
yield
protein
recombin
dna
transfect
anim
cell
either
integr
stabl
express
host
genom
maintain
episom
form
transient
express
stabl
express
system
foreign
gene
pass
next
descend
express
maintain
gener
gener
induc
promot
may
requir
induc
deplet
addit
specif
nutrient
ph
chang
chang
physicochem
factor
order
initi
process
gene
express
induc
system
suffer
disadvantag
chemic
induc
may
expens
toxic
would
requir
elimin
downstream
process
product
intend
human
usag
thu
usag
thermoregul
system
use
product
recombin
pharmaceut
protein
express
depend
upon
strong
heatregul
promot
minim
risk
addit
chemic
agent
cellular
structur
bacteria
rapidli
adapt
cultur
condit
short
replic
time
min
media
requir
bacteri
cell
simpl
consist
simpl
carbon
nitrogen
sourc
thu
overal
input
bacteria
lower
mammalian
cell
approv
bacteriaderiv
either
european
union
fda
usa
therapeut
includ
hormon
human
insulin
insulin
analog
calcitonin
human
growth
hormon
glucagon
parathyroid
hormon
somatropin
insulinlik
growth
factor
interferon
interleukin
light
heavi
chain
rais
vascular
endotheli
growth
factora
tumor
necrosi
factor
alpha
cholera
b
subunit
protein
granulocyt
colonystimul
factor
plasminogen
activ
microb
first
choic
product
recombin
protein
enterobacterium
e
coli
system
offer
quick
easi
modif
eas
grow
manag
environment
condit
short
life
cycl
bacteri
cell
toler
adapt
chang
environ
rapidli
thu
scaleup
easier
howev
system
suffer
disadvantag
human
mammalian
gene
clone
bacteria
undergo
splice
due
lack
splice
machineri
thu
intronless
version
gene
clone
optimum
result
fig
signal
involv
transcript
gene
may
vari
thu
gene
interest
usual
fuse
bacteri
gene
control
promot
protein
obtain
fusion
product
later
cleav
purifi
usedlac
promot
one
popular
bacteri
promot
howev
highlevel
express
promoteri
also
prefer
present
pet
vector
drive
target
protein
express
nearli
total
cell
protein
gene
interest
place
control
regul
promoterof
phagefor
translat
abund
trna
relat
frequenc
appear
differ
codon
codon
bias
therefor
codon
rare
e
coli
may
caus
amino
acid
misincorpor
prematur
termin
affect
yield
therapeut
protein
solv
either
sitedirect
replac
rare
codon
codon
amino
acid
prefer
e
coli
anoth
approach
may
coexpress
rare
trna
e
coli
strain
e
coli
codon
plu
rosetta
design
purpos
addit
amino
acid
process
translat
one
codon
sever
amino
acid
thu
codon
bias
occur
prefer
particular
codon
amino
acid
particular
speci
fig
complex
eukaryot
cell
advantag
produc
fulli
function
properli
fold
protein
antibodi
four
subunit
may
secret
eukaryot
cell
fulli
function
form
hand
difficult
obtain
multidomain
protein
e
coli
even
protein
obtain
renatur
fold
laboratori
condit
may
either
expens
protein
may
lack
activitylack
posttransl
modif
ptm
problem
solv
mandatori
activ
mani
therapeut
protein
glycosyl
common
modif
other
phosphoryl
format
disulfid
bond
essenti
requir
full
function
capabl
mani
human
protein
ptm
play
import
role
proper
protein
fold
process
stabil
tissu
target
activ
immun
reactiv
halflif
protein
lack
result
insolubl
unstabl
inact
producthowev
nlink
glycosyl
system
campylobact
jejuni
success
transfer
e
coli
thu
open
possibl
product
glycosyl
protein
certain
mutant
e
coli
develop
promot
disulfid
bond
format
origami
rosettagami
reduc
proteas
activ
overproduct
recombin
protein
bacteria
might
result
loss
solubl
deposit
mani
protein
speci
protein
aggreg
inclus
bodi
alter
growth
condit
might
render
product
insolubl
form
mani
eukaryot
protein
found
trap
inclus
bodi
resist
process
success
obtain
purif
insulin
betaferon
inclus
bodi
retriev
protein
use
denatur
condit
subsequ
refold
renatur
might
alway
easi
prove
extrem
expensivewith
e
coli
host
difficult
obtain
protein
larger
kda
solubl
formdu
certain
limit
product
protein
e
coli
host
system
discuss
product
protein
coval
attach
carbohydr
group
protein
form
glycoprotein
call
glycosyl
glycoprotein
protein
constitut
major
fraction
play
import
role
variou
physiolog
process
compon
cell
membran
carbohydr
commonli
attach
protein
may
fucos
fuc
galactos
gal
nacetylgalactosamin
galnac
glucos
glc
nacetylglucosamin
glcnac
mannos
man
sialic
acid
sia
sugar
moieti
may
associ
amid
nitrogen
atom
side
chain
asparagin
asn
term
nlink
glycosyl
oxygen
atom
side
chain
serin
ser
threonin
thr
term
olink
glycosyl
asparagin
asn
present
polypeptid
accept
carbohydr
moieti
residu
sequenc
asnxser
asnxthr
x
amino
acid
except
prolin
target
glycosyl
residu
sequenc
aspect
structur
protein
cell
type
determin
glycosyl
site
nlink
sugar
residu
common
core
pentasaccharid
pentasaccharid
consist
three
mannos
two
nacetylglucosamin
residu
core
may
attach
differ
oligosaccharid
form
differ
glycoprotein
glycosyl
one
import
posttransl
modif
occur
insid
lumen
endoplasm
reticulum
er
golgi
complex
er
golgi
complex
import
protein
target
transport
nlink
glycosyl
start
endoplasm
reticulum
continu
golgi
complex
polypeptid
synthes
ribosom
howev
olink
glycosyl
exclus
occur
golgi
complex
process
oligosaccharid
attach
protein
associ
special
lipid
present
er
dolichol
phosphat
consist
isopren
unit
phosphat
dolichol
phosphat
oligosaccharid
transfer
specif
asparagin
residu
polypeptid
chain
ribosom
enzym
respons
glycosyl
protein
activ
oligosaccharid
locat
lumen
side
er
transport
golgi
complex
carbohydr
unit
alter
final
golgi
complex
respons
olink
sugar
attach
modif
nlink
sugar
protein
target
transport
destin
chaperon
famili
highli
conserv
differ
protein
import
function
chaperon
prevent
aggreg
misfold
newli
synthes
polypeptid
chainthey
prevent
irrevers
aggreg
nonn
conform
maintain
protein
product
fold
pathwaythey
prevent
nonproduct
interact
compon
cellthey
help
guid
direct
assembl
multisubunit
protein
complex
larger
proteinsth
chaperon
involv
fold
recogn
nonn
substrat
protein
mainli
via
expos
hydrophob
residu
major
class
molecular
chaperon
heat
shock
protein
present
varieti
system
prevent
damag
protein
high
tetradecamer
mitochondri
chaperoninit
implic
protein
import
macromolecular
assemblyrequir
fold
precursor
polypeptid
atpdepend
mannerprev
aggreg
mediat
refold
protein
heat
shock
central
compon
cellular
network
fold
catalyst
molecular
chaperonesthey
assist
differ
type
process
protein
fold
cell
transient
associ
substrat
bind
domain
short
hydrophob
peptidethey
bind
releas
substrat
switch
lowaffin
atpbound
state
highaffin
adpbound
statethey
form
complex
network
fold
machin
highli
abund
chaperoneit
play
import
role
mani
cellular
process
exampl
cell
cycl
control
cell
surviv
hormon
signal
pathwaysit
key
player
maintain
cellular
homeostasi
stressha
atpas
activ
whose
bind
hydrolysi
affect
conform
dynam
proteinit
becom
major
therapeut
target
cancer
role
explor
neurodegen
disord
infecti
diseas
cct
chaperonin
contain
eukaryot
chaperonin
tailless
complex
polypeptid
ring
complex
tric
facilit
proper
fold
mani
cellular
protein
groelit
bacteri
chaperoneit
bind
partial
fold
misfold
proteinsfor
function
groel
requir
cofactor
groe
differ
nglycosyl
yeast
high
hypermannos
highli
immunogen
unmodifi
protein
suitabl
product
yeast
member
fungi
pichia
pastori
pichia
methanolica
candida
boidinii
pichia
angusta
facult
methylotroph
yeasthav
great
potenti
pichia
pastori
favor
high
cell
densiti
obtain
protein
secret
high
concentr
gl
less
hypermannosyl
compar
yeast
thu
less
immunogen
howev
disadvantag
requir
methanol
induc
gene
express
transgen
control
promot
alcohol
oxidas
gene
methanol
may
flammabl
toxic
cell
human
thoroughli
remov
hypermannosetyp
glycosyl
fungi
also
unsuit
product
mani
recombin
protein
insect
cell
insect
cell
infect
baculovirus
doublestrand
circular
dna
virus
arthropod
host
baculovirusmedi
gene
express
insect
method
choic
costeffect
give
much
higher
yield
recombin
protein
compar
system
possibl
produc
larg
protein
result
product
correctli
process
biolog
activ
protein
baculoviru
autographa
californica
nuclear
polyhedrosi
viru
acmnpv
use
clone
vector
insect
cell
line
viral
polyhedron
protein
use
requir
normal
habitat
exhibit
high
rate
transcript
need
cell
cultur
thu
code
sequenc
gene
replac
foreign
dna
gene
transcrib
control
power
polyhedron
promoterwith
high
yield
total
cell
protein
observ
yield
may
variabl
due
cours
viru
infect
viral
titer
product
recombin
protein
insect
cell
time
consum
compar
bacteri
system
cell
growth
slow
cost
medium
high
everi
time
fresh
cell
requir
viral
infect
lethal
cell
also
limit
perform
posttransl
modif
perform
nonsyal
nlink
glycosyl
optim
need
perfect
yield
depend
upon
viru
titer
time
taken
infect
express
insect
cell
prefer
activ
protein
difficult
obtain
e
coli
system
genet
engin
use
select
invitrogen
transgen
cell
line
express
necessari
enzym
obtain
human
complex
nlink
glycosyl
pattern
system
extens
use
structur
studi
correctli
fold
eukaryot
protein
may
obtain
secret
form
simplifi
purif
protocol
approv
biopharmaceut
infect
insect
cell
line
hi
five
cervarix
recombin
papillomaviru
ctermin
truncat
major
capsid
protein
type
use
cancer
vaccin
glycosyl
problem
encount
insect
cell
use
product
recombin
human
glycosyl
protein
lot
genet
engin
requir
produc
humanlik
glycosyl
insect
cell
thu
prefer
system
therapeut
human
protein
product
mammalian
system
chines
hamster
ovari
cell
line
due
time
difficultli
maintain
insect
cell
mammalian
cell
explor
product
recombin
protein
mammalian
cell
properti
protein
fold
assembl
posttransl
modif
becom
prefer
system
protein
product
account
major
recombin
protein
product
recombin
therapeut
product
use
clinic
applic
produc
mammalian
cell
mammalian
cell
maintain
serumbloodplasmabas
medium
therefor
presenc
infecti
agent
product
might
deleteri
properli
remov
infect
may
rang
hiv
coronaviru
sever
acut
respiratori
syndrom
sar
nonlipidenvelop
nle
virus
circovirus
torqu
tenoviru
ttv
torqu
tenominiviru
ttmv
hbv
hcv
htlv
human
tcell
lymphotrop
viru
west
nile
viru
prion
selfrepl
infecti
protein
may
also
present
may
lead
variant
diseas
vcjd
pathogen
transmiss
major
concern
manufactur
bloodderiv
coagul
factor
earli
factor
replac
product
deriv
plasma
use
treat
hemophilia
found
contamin
hiv
hbv
hcv
virus
year
usbas
hemophil
patient
infect
hivand
infect
hcv
parvovirus
present
contamin
plasmaderiv
factor
viii
therefor
product
urgent
requir
regulatori
measur
came
first
recombin
factor
viii
advat
baxter
usa
advat
produc
cho
cell
grown
serumfre
proteinfre
medium
ultrafilt
soybean
peptid
subsequ
purif
immunoaffin
chromatographi
usag
advat
help
elimin
risk
transmit
emerg
blood
pathogen
prionspos
seriou
risk
highli
resist
physicalchem
inactiv
earli
stage
prion
infect
almost
imposs
detect
plasma
donor
iatrogen
transmiss
prion
occur
patient
receiv
humanderiv
pituitari
hormon
human
growth
hormon
hgh
gonadotropin
cjd
transmit
recipi
cadaver
pituitari
hgh
withdraw
cadaver
pituitaryderiv
gonadotropin
infertil
associ
iatrogen
transmiss
cjd
later
cadaver
pituitari
hgh
gonadotropin
replac
recombin
gh
produc
microbi
system
recombin
gonadotropin
produc
cho
cell
line
human
cell
line
human
cell
linederiv
dynepoerithropoietin
erythropoietin
increas
shelf
life
lysosom
enzym
replagalalfagalactosidas
lysosom
hydrolas
approv
european
union
eu
food
drug
administr
fda
usa
product
fulli
glycosyl
express
human
cell
linesand
use
therapeut
human
be
transgen
anim
success
use
product
recombin
protein
detail
refer
chap
protein
product
pose
great
risk
term
safeti
transmiss
infecti
agent
allerg
respons
immun
reactiv
autoimmun
respons
might
occur
atryn
approv
approv
european
medic
agenc
fda
recombin
biopharmaceut
use
transgen
anim
contain
human
antithrombin
glycosyl
moieti
secret
milk
transgen
goat
rhucin
intend
acut
attack
angioedema
patient
congenit
inhibitor
activ
defici
obtain
transgen
rabbit
deni
approv
transgen
plant
explor
recombin
protein
produc
research
diagnost
use
transgen
express
construct
chimer
structur
surround
variou
activ
regulatori
element
polyadenyl
site
play
import
role
high
level
express
transgen
cauliflow
mosaic
viru
camv
promoterwork
well
dicot
strong
constitut
promoterthat
made
activ
duplic
enhanc
region
howev
monocot
maiz
promot
prefer
promot
presenc
intron
region
enhanc
transcript
monocot
obtain
high
yield
protein
sever
factor
may
appropri
consid
incorpor
polyadenyl
site
may
camv
transcript
agrobacterium
tumefacien
no
gene
pea
ssu
geneth
yield
control
place
gene
control
promoterwhich
activ
particular
tissu
development
stage
particular
environ
eg
rice
glutelin
pea
legumin
usag
induc
promot
eg
tomato
coa
mechan
gene
activ
system
develop
cramer
crop
tech
corp
virginia
usa
transcript
start
harvest
tobacco
leav
shear
processingcodon
bia
host
plant
may
overcom
engin
transgen
posit
might
lead
truncat
andor
misincorpor
slow
processsubcellular
target
also
import
factor
affect
process
fold
assembl
posttransl
modif
effici
achiev
inclus
ntermin
signal
peptideposit
transgen
integrationstructur
transgen
locusgen
copi
numberpres
truncat
rearrang
transgen
copi
affin
tag
flag
epitop
use
eas
process
purif
howev
modif
affect
primari
structur
also
properti
protein
figur
show
gener
vector
pcambia
small
size
kb
maintain
high
copi
number
replicon
impart
chloramphenicol
kanamycin
resist
high
stabil
agrobacterium
use
transgen
express
plant
modifi
vector
shown
success
insulinproduct
nowaday
plant
system
effici
engin
produc
human
growth
hormon
human
serum
albumin
erythropoietin
antibodi
scfv
toxin
subunit
vaccin
insulin
recombin
protein
product
requir
precaut
result
loss
yield
andor
product
contamin
stage
contamin
might
occur
sourc
pose
big
challeng
may
advers
contamin
materi
put
human
usageimmun
respons
therapeut
agent
bodi
mount
immun
reaction
lead
deposit
immun
complex
variou
tissu
condit
anaphylact
shock
might
occur
eg
essenti
agent
lost
sinc
birth
like
factor
viii
patient
might
rais
antibodi
respons
treatment
also
occur
antibodi
use
therapeut
agent
treatment
varieti
cancersprotein
aggreg
nonfunct
condit
might
result
aggreg
loss
activ
recombin
proteinposttransl
modif
fold
purif
proper
modif
refold
requir
therapeuticsdisulfid
bond
format
stabil
protein
structur
thu
strategi
specif
extracellular
excret
pathway
overexpress
chaperon
requir
optimum
productiondegrad
sometim
protein
activ
host
cell
like
proteas
proteinmodifi
chemic
might
degrad
recombin
protein
eg
peg
interferon
modifi
polyethylen
glycol
prolong
presenc
reduct
enzymat
degrad
renal
clearanc
thu
extend
presenc
lesser
immunogen
plasminogen
activ
great
clinic
relev
manag
stroke
myocardi
infarct
product
tpa
e
coli
yeastsystem
work
properli
due
lack
posttransl
modif
glycosyl
respect
novel
truncat
form
tpa
improv
fibrin
affin
increas
resist
express
cho
express
system
therapeut
protein
produc
stabli
transfect
cho
cell
line
cell
lineswer
maintain
serumfre
medium
glutamin
hypoxanthin
thymin
stir
tank
bioreactor
cell
grown
rpm
humid
protein
purifi
higher
yield
fig
factor
viii
one
import
factor
blood
clot
factor
defici
factor
viii
caus
bleed
disord
call
hemophilia
hemophilia
may
mild
sever
depend
upon
factor
viii
concentr
bodi
moder
sever
factor
viii
defici
spontan
bleed
episod
joint
hemophilia
affect
male
replac
therapi
treatment
option
hemophiliac
either
human
plasmaderiv
factor
viii
pdfviii
recombin
fviii
rfviii
transfect
hek
cell
cultur
serumfre
suspens
tri
optim
yield
recombin
factor
viii
rfviii
produc
cultur
mammalian
cell
babi
hamster
kidney
bhk
chines
hamster
ovari
cell
cho
use
largescal
bioreactor
standard
done
maxim
yield
insulin
peptid
hormon
consist
amino
acid
secret
cell
islet
langerhan
pancrea
hormon
respons
maintain
normal
blood
glucos
level
blood
insulin
store
form
proinsulin
contain
two
polypeptid
chain
b
connect
third
peptid
c
chain
secret
cleav
product
insulin
cchain
cleavag
result
remov
cchain
amino
acid
b
chain
amino
acid
link
disulfid
linkag
form
matur
insulin
begin
effort
made
isol
mrna
pre
proinsulin
rat
islet
langerhan
pancrea
synthes
cdna
thereaft
insert
plasmid
recombin
plasmid
transfer
e
coli
cell
secret
proinsulin
scientist
chemic
synthes
dna
sequenc
two
chain
b
insulin
separ
insert
two
plasmid
side
gene
recombin
plasmid
separ
transfer
e
coli
cell
secret
fuse
chain
chain
separ
chain
isol
pure
form
detach
yield
g
healthi
transform
cell
product
recombin
insulin
shown
fig
b
growth
hormon
produc
anterior
lobe
pituitari
gland
releas
multipl
puls
hgh
encod
ghn
gene
cluster
array
five
close
relat
gene
local
chromosom
belong
divers
gene
famili
evolv
gene
duplic
event
lot
structur
similar
common
function
variou
form
predomin
form
hgh
kda
protein
amino
acid
two
disulfid
bond
gh
control
function
directli
act
certain
hormon
somatomedin
activ
exampl
insulinlik
growth
factor
wide
spectrum
role
play
promot
long
bone
growth
promot
normal
sex
organ
develop
puberti
regul
metabol
stimul
tissu
growth
repair
anabolicanticatabol
effect
via
improv
nitrogen
retent
modul
bone
miner
densiti
metabol
throughout
life
prolifer
cell
type
immun
system
appetit
stimul
breakdown
fat
lipolysi
clinic
condit
therapi
growth
hormon
given
treatment
dwarfism
bone
fractur
skin
burn
bleed
ulcer
aid
recombin
human
growth
hormon
rhgh
kda
consist
long
chain
amino
acid
use
defici
disord
growth
hormon
children
use
growth
abnorm
short
statur
use
chronic
renal
insuffici
therapi
growth
hormon
also
approv
adult
growth
hormon
defici
gh
one
wide
use
hormon
estim
market
billion
usd
long
experi
administr
proven
therapi
safe
effect
variou
condit
growth
abnorm
earlier
pituitaryderiv
hgh
use
later
prohibit
found
associ
diseas
recombin
dna
technolog
safe
abund
recombin
hgh
produc
variou
heterolog
system
nonglycosyl
human
growth
hormon
biolog
activ
thu
prefer
system
product
e
coli
allow
rapid
econom
product
larg
amount
recombin
hgh
rhgh
use
treat
ghdefici
ghd
shortstatur
childrenacceler
wound
healingincreas
insulinlik
growth
factor
igf
levelsrhgh
increas
osteocalcin
type
procollagen
propeptid
picp
bone
densiti
administ
children
ghd
optim
product
strong
induc
promotersar
prefer
ipl
ipr
trc
e
coli
advantag
drive
overproduct
recombin
protein
apart
e
coli
human
somatotropin
hst
express
tri
biolog
activ
disulfidebond
form
tobacco
chloroplast
hormon
use
treatment
hypopituitari
dwarfism
children
addit
indic
treatment
turner
syndrom
chronic
renal
failur
hiv
wast
syndrom
possibl
treatment
elderli
growth
hormonedefici
human
occur
children
adult
interferon
group
protein
secret
respons
viral
infect
resist
impart
inf
short
live
last
forev
famili
natur
occur
protein
made
secret
cell
lymphocyt
modul
respons
cell
immun
system
virus
bacteria
cancer
interferon
produc
either
establish
cell
line
lymphoblastoid
fresh
cell
isol
blood
product
involv
induct
viru
prime
incub
interferon
interferon
result
better
yield
affin
chromatographi
monoclon
antibodi
pack
column
help
purif
interferon
clinic
usag
remov
inactiv
viru
import
interferon
therapi
use
cancer
viral
infect
multipl
sclerosi
chronic
granulomat
diseas
multiferon
natur
consist
sever
subtyp
cancer
like
merkel
cell
carcinoma
type
interferon
multiferon
mix
variou
subtyp
highli
effect
chap
interferon
mention
protein
therapeut
interferon
market
roferona
infergen
intron
hematopoiet
growth
factor
consist
cytokin
protein
hormonesproduc
bodi
govern
product
matur
variou
cell
produc
process
hematopoiesi
bone
marrow
hematopoiet
stem
cell
precursor
cell
presenc
particular
growth
factor
differenti
becom
special
kind
cell
monocyt
macrophag
lymphocyt
red
blood
cell
one
import
growth
factor
erythropoietin
protein
hormoneproduc
specif
type
cell
kidney
presenc
erythropoietin
progenitor
cell
stimul
bone
marrow
form
matur
erythrocyt
red
blood
cell
thu
patient
chronic
kidney
diseas
unabl
maintain
adequ
amount
erythropoietin
normal
develop
erythrocyt
blood
result
low
number
red
blood
cell
subsequ
anemia
patient
either
requir
blood
transfus
erythropoietin
outsid
suppli
limit
natur
sourc
kidney
cell
thu
recombin
human
erythropoietin
amgen
trade
name
epoetin
alfa
market
anem
condit
involv
erythropoietin
human
gene
encod
erythropoietin
clone
chines
hamster
ovari
cell
linefor
product
human
protein
cell
linecontinu
use
today
product
halflif
erythropoietin
increas
incorpor
glycosyl
protein
growth
factor
thu
analog
engin
two
extra
amino
acid
substrat
glycosyl
thu
product
done
cho
cell
line
product
five
nlink
sugar
chain
almost
three
time
longer
life
erythropoietin
pdgf
regul
cell
growth
divis
play
signific
role
blood
vessel
format
angiogenesi
growth
blood
vessel
alreadi
exist
blood
vessel
tissu
may
act
autocrin
paracrin
stimul
cell
growth
vivo
pdgf
play
role
develop
cell
prolifer
cell
migrat
angiogenesi
link
atherosclerosi
fibrosi
malign
diseas
pdgf
five
differ
isoform
pdgfa
pdgfb
pdgfc
pdgfd
ab
heterodim
pdgfa
pdgfb
similar
amino
acid
sequenc
experi
suggest
differ
biolog
function
two
chain
differ
locat
differ
transcript
control
pgdfaa
releas
medium
pdgfbb
insuffici
secret
remain
attach
plasma
membran
pgdfbb
pdgfab
strong
mitogen
probabl
respons
biolog
role
pdgf
pdgf
receptor
pdgfr
receptor
tyrosin
kinas
rtk
alpha
beta
type
upon
activ
pdgf
receptor
dimer
lead
autophosphoryl
sever
site
cytosol
domain
pdgf
mitogen
promot
prolifer
fibroblast
smooth
muscl
cell
vitro
pdgf
show
consider
heterogen
size
kda
howev
purifi
pdgf
cation
protein
kda
recombin
human
plateletderiv
growth
factor
rhpdgf
first
recombin
protein
approv
us
food
drug
administr
treatment
chronic
foot
ulcer
diabet
patient
regranex
ethicon
inc
somervil
nj
potenti
use
bone
regener
increas
bone
densiti
long
bone
spine
pdgf
commerci
produc
use
e
coli
mammalian
cell
human
egf
protein
three
intracellular
disulfid
bond
play
import
role
regul
cell
growth
prolifer
show
strong
sequenti
function
homolog
human
type
alpha
transform
growth
factor
htgf
alpha
competitor
egf
receptor
site
egf
act
bind
high
affin
egfr
cell
surfac
stimul
intrins
protein
tyrosin
kinas
activ
egf
mani
biolog
activ
initi
observ
center
around
prolif
effect
fibroblast
keratinocyt
epitheli
cell
egf
modul
lutein
hormoneand
thyroid
hormon
egf
produc
commerci
engin
e
coli
system
also
explor
optimum
egf
product
fgfi
involv
stimul
collater
vascular
recoveri
ischemia
well
enhanc
wound
heal
nerv
regener
repair
cartilag
altern
refer
pluripot
capabl
develop
one
cell
type
tissu
growth
factor
promiscu
biochemistri
pharmacolog
concept
varieti
molecul
bind
elicit
respons
singl
receptor
growth
factor
due
multipl
action
multipl
cell
type
fgf
smallmolecul
fgfreceptor
kinas
inhibitor
use
treatment
cancer
cardiovascular
diseas
potenti
treatment
metabol
syndrom
hypophosphatem
diseas
receptor
tyrosin
kinas
inhibitor
sunitinib
approv
indic
renal
cell
carcinoma
gastrointestin
stromal
tumorssmal
fgfr
inhibitor
nordihydroguaiaret
acid
effect
multipl
myeloma
cell
induc
cell
cycl
arrest
endometri
cancer
cell
mutat
antibodi
shown
effect
caus
apoptosi
mous
model
multipl
myeloma
bladder
cancer
thu
fgfr
inhibit
effect
treatment
cancer
nerv
growth
factor
ngf
import
member
famili
neurotrophin
five
protein
nerv
growth
factor
neurotrophin
famili
import
regul
develop
nervou
system
play
import
role
maintain
structur
plastic
repair
adult
nervou
system
neurotrophin
basic
protein
share
sequenc
homolog
highli
conserv
mammalian
speci
nerv
growth
factor
ngf
small
secret
protein
induc
differenti
surviv
particular
target
neuron
nerv
cell
littl
known
biolog
action
neurotrophin
apart
ngf
nucleotid
sequenc
cdna
predict
ngf
synthes
preprongf
upon
remov
hydrophob
signal
either
kda
kda
prongf
gener
depend
size
transcript
howev
process
precursor
differ
tissu
well
understood
essenti
normal
develop
growth
differenti
sympathet
sensori
neuron
also
essenti
maintain
normal
function
cell
adult
thu
import
matur
surviv
neuron
prevent
degener
adult
neuron
apart
import
role
nervou
system
shown
possess
protect
action
human
pressur
ulcer
corneal
ulcer
glaucoma
reduc
sensat
may
observ
leprosi
wound
heal
nerv
injuri
diabet
ngf
may
help
regul
sensori
fiber
sensit
function
directli
indirectli
stimul
effector
administr
recombin
ngf
may
improv
sensat
pain
cholinerg
neuron
basal
forebrain
show
receptor
ngf
specif
mrna
variou
ngf
identifi
differ
area
brain
cholinerg
neuron
loss
cardin
featur
alzheim
diseas
nerv
growth
factor
ngf
stimul
cholinerg
function
improv
memori
prevent
cholinerg
degener
anim
model
injuri
amyloid
overexpress
age
ngf
act
intracellular
calcium
tyrosin
kinas
receptor
mechan
nerv
growth
factor
enhanc
earli
regener
sever
exon
also
import
maintain
biochem
morpholog
phenotyp
matur
basal
forebrain
cholinerg
neuron
bfcnl
lesion
injuri
central
nervou
system
cn
thu
ngf
may
provid
therapeut
option
prevent
death
cholinerg
neuron
clinic
condit
produc
use
e
coli
exert
function
autocrin
endocrin
fashion
variou
cell
type
ectoderm
origin
includ
epitheli
cell
normal
transmembran
protein
function
cell
commun
abil
activ
receptor
tyrosin
kinas
ectodomain
cleav
highli
regul
manner
releas
solubl
activ
paracrin
signal
receptor
egftgf
alpha
receptor
therefor
focu
understand
import
role
egf
receptor
signal
carcinoma
develop
larg
group
relat
protein
famili
member
includ
bone
morphogenet
protein
bmp
growth
differenti
factor
gdp
affect
tissu
remodel
wound
repair
hematopoiesi
morphogenesi
embryon
develop
adult
stem
cell
differenti
immun
regul
switch
factor
iga
inflamm
exist
multipl
form
act
transmembran
serinethreonin
receptor
kinas
lead
activ
smad
act
tumor
suppressor
cancer
initi
promot
tumor
progress
role
control
embryon
develop
cellular
differenti
hormonesecret
immun
function
role
mesenchym
differenti
factor
focu
muscl
fat
bone
cell
might
provid
insight
deregul
skelet
development
diseas
area
activ
research
produc
use
cho
cell
line
huge
potenti
futur
therapi
use
protein
therapeut
agent
recombin
protein
benefici
research
engin
improv
activ
prolong
stay
bodi
exampl
engin
monoclon
antibodi
toxin
radioisotop
gener
bispecif
antibodi
still
technolog
struggl
hard
make
diseas
complet
text
book
societi
free
diseas
pathogen
function
protein
bodi
initi
transcriptionmedi
metabol
processesact
enzymesal
purpos
recombin
dna
technolog
gene
clone
e
coli
product
costeffectivemammalian
cell
may
use
productionnon
advantag
use
e
coli
host
product
recombin
protein
easi
scaleup
simpl
media
requirementcan
easili
perform
splice
foreign
dnaproduc
process
properli
modifi
proteinal
limit
e
coli
pose
problem
recombin
protein
product
codon
biasingsplicingposttransl
modificationnon
fungal
eukaryot
offer
tremend
advantag
recombin
protein
product
proper
protein
foldingposttransl
modificationhypermannosylationeasi
scaleup
insect
cell
may
infect
viral
vector
product
recombin
protein
retroviru
coronaviru
baculovirusparvoviru
commonli
use
mammalian
cell
line
bhkchohelaal
need
serum
plasmafre
medium
product
therapeut
protein
cost
high
thu
cost
product
highrisk
transmiss
unknown
pathogen
lead
diseasesvari
lot
result
differ
yieldnon
first
recombin
protein
releas
market
activasehumulintrastuzumabal
growth
factor
inhibitor
find
place
therapeut
growth
factor
harmfulgrowth
factor
deactiv
lead
healthi
bodygrowth
factor
requir
progress
tumorsal
darbepoetin
use
treatment
short
statureanemiablood
clottingnon
b
c
c
c
b
b
b
c
b
advantag
disadvantag
use
e
coli
host
product
recombin
protein
role
codon
bias
express
foreign
gene
posttransl
modif
write
note
fungal
host
product
insect
cell
prefer
recombin
protein
product
write
note
insulin
b
factor
viii
c
gh
tissu
plasminogen
write
trade
name
insulin
tpa
gh
